Health and cost impact of stepping down asthma medication for UK patients, 2001-2017: A population-based observational study.

PLoS Medicine
Chloe I BloomJennifer K Quint

Abstract

Guidelines recommend stepping down asthma treatment to the minimum effective dose to achieve symptom control, prevent adverse side effects, and reduce costs. Limited data exist on asthma prescription patterns in a real-world setting. We aimed to evaluate the appropriateness of doses prescribed to a UK general asthma population and assess whether stepping down medication increased exacerbations or reliever use, as well as its impact on costs. We used nationwide UK primary care medical records, 2001-2017, to identify 508,459 adult asthma patients managed with preventer medication. Prescriptions of higher-level medication: medium/high-dose inhaled corticosteroids (ICSs) or ICSs + add-on medication (long-acting β2-agonist [LABA], leukotriene receptor antagonist [LTRA], theophylline, or long-acting muscarinic antagonist [LAMA]) steadily increased over time (2001 = 49.8%, 2017 = 68.3%). Of those prescribed their first preventer, one-third were prescribed a higher-level medication, of whom half had no reliever prescription or exacerbation in the year prior. Of patients first prescribed ICSs + 1 add-on, 70.4% remained on the same medication during a mean follow-up of 6.6 years. Of those prescribed medium/high-dose ICSs as their first p...Continue Reading

References

Jun 9, 2001·The Journal of Allergy and Clinical Immunology·S Suissa, P Ernst
Feb 28, 2002·The European Respiratory Journal·V Giraud, N Roche
Jan 20, 2004·Pediatric Pulmonology·Amanda L GriffithsNicholas Freezer
Apr 16, 2004·The European Respiratory Journal·M MasoliR Beasley
May 6, 2006·The Journal of Allergy and Clinical Immunology·Michael SchatzE Francis Cook
Jun 8, 2006·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Mike ThomasDavid Price
Jul 17, 2007·Respiratory Medicine·Marie-Claude BretonLucie Blais
Feb 1, 2011·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Scott T Anderson, Nicholas Capozzoli
Oct 27, 2012·Respiratory Medicine·UNKNOWN Inhaler Error Steering CommitteeJ Bousquet
Oct 1, 2013·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M PatelUNKNOWN SMART Study Group
Dec 18, 2013·The Journal of Allergy and Clinical Immunology·Julia F SlejkoPatrick W Sullivan
Jun 24, 2014·Journal of Evaluation in Clinical Practice·Marjolein LugtenbergGert P Westert
Jun 8, 2015·International Journal of Epidemiology·Emily HerrettLiam Smeeth
Jun 20, 2015·The Cochrane Database of Systematic Reviews·Shaleen AhmadRebecca Normansell
Oct 28, 2015·The Journal of Allergy and Clinical Immunology·Matthew A RankNilay D Shah
Jul 28, 2016·BMC Family Practice·Bjarne AustadAnne-Sofie Helvik
Aug 16, 2016·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Sunny JabbalBrian Lipworth
Dec 17, 2016·The Journal of Allergy and Clinical Immunology·Tari HaahtelaEeva Reissell
Jan 24, 2017·JAMA : the Journal of the American Medical Association·Shawn D AaronUNKNOWN Canadian Respiratory Research Network
Feb 2, 2017·The Cochrane Database of Systematic Reviews·Iain CrossinghamPaul A Marsden
Mar 14, 2017·The Cochrane Database of Systematic Reviews·Rebecca NormansellAlexander G Mathioudakis
Aug 13, 2017·BMJ Open·Francis NissenJennifer K Quint
Jan 13, 2018·Annals of the American Thoracic Society·Tursynbek NurmagambetovPaul Garbe
May 5, 2018·Thorax·Stephen J FowlerDominick Shaw
May 17, 2018·The New England Journal of Medicine·Eric D BatemanJ Mark FitzGerald
May 17, 2018·The New England Journal of Medicine·Paul M O'ByrneHelen K Reddel
Dec 7, 2018·American Journal of Respiratory and Critical Care Medicine·Chloe I BloomPaul Cullinan
Jan 16, 2019·American Journal of Respiratory and Critical Care Medicine·Richard BeasleyIan D Pavord
Feb 9, 2019·BMJ : British Medical Journal·Anthony J Avery, Brian G Bell
May 22, 2019·The New England Journal of Medicine·Richard BeasleyUNKNOWN Novel START Study Team
Sep 26, 2019·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·C I BloomJ K Quint

❮ Previous
Next ❯

Citations

Dec 4, 2020·BMJ Open Respiratory Research·Roshni PatelChloe I Bloom
Apr 15, 2021·Drug and Therapeutics Bulletin
May 26, 2021·Expert Review of Respiratory Medicine·Mario CazzolaJosuel Ora

❮ Previous
Next ❯

Software Mentioned

GINA

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.